Abstract
This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Current Bioactive Compounds
Title:Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract
Volume: 12 Issue: 1
Author(s): Fatah Keffous, Nasser Belboukhari, Houria Djaradi, Abdelkrim Cheriti, Khaled Sekkoum and Hassan Y. Aboul-Enein
Affiliation:
Keywords: Antioxidant capacity, cyclic voltammetry, reducing power, total flavonoids, total phenolics, Zilla macroptera.
Abstract: This paper describes a study of the content of total phenolic contents, the antioxidant capacity and the cyclic voltammetry of Zilla macroptera aqueous extract. The results demonstrate that the content of total phenolics was 89±2.46 g of Gallic acid equivalence per 1 mg of extract and the content of total flavonoids was 12.99±0.67 µg of Quercetin equivalency per 1 mg of extract. Four methods ‘‘in vitro’’ were used to evaluate the antioxidant capacity of Zilla macroptera aqueous extract. The reducing power test showed that the sample has an equivalent activity of 63.16±1.09 µg of Ascorbic acid for 1 mg of extract. The total antioxidant capacity presented an equivalent capacity of 25±0.94 µg of Ascorbic acid per 1 mg of extract. The voltammogram indicates two potentials oxidation peaks; 0.6 V and 0.92 V towards the reference electrode (Ag / AgCl).
Export Options
About this article
Cite this article as:
Keffous Fatah, Belboukhari Nasser, Djaradi Houria, Cheriti Abdelkrim, Sekkoum Khaled and Y. Aboul-Enein Hassan, Total Antioxidant Capacity, Reducing Power and Cyclic Voltammetry of Zilla Macroptera (Brassicaceae) Aqueous Extract, Current Bioactive Compounds 2016; 12 (1) . https://dx.doi.org/10.2174/1573407212666160210230707
DOI https://dx.doi.org/10.2174/1573407212666160210230707 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effects of Tea Catechins on Inflammation-Related Cardiovascular Diseases
Current Immunology Reviews (Discontinued) Editorial (Thematic Issue: Treating Major Age-Related Diseases in Older and Oldest Old Patients)
Current Pharmaceutical Design The Use of Mesenchymal Stem Cells and their Derived Extracellular Vesicles in Cardiovascular Disease Treatment
Current Stem Cell Research & Therapy Drugs Polypharmacology by In Silico Methods: New Opportunities in Drug Discovery
Current Pharmaceutical Design Pulmonary Vascular Function in Insulin Resistance and Diabetes
Current Vascular Pharmacology A Scientometrics Analysis and Visualization of Depressive Disorder
Current Neuropharmacology Pre-Clinical and Clinical Evaluation of Nuclear Tracers for the Molecular Imaging of Vulnerable Atherosclerosis: An Overview
Current Medicinal Chemistry Novel Peptides: An Alternative Approach for the Treatment of Diabetes Mellitus
Current Drug Therapy Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside
Current Vascular Pharmacology Future Preventive and Therapeutic Targets for Transfusion-Related Acute Lung Injury
Current Pharmaceutical Design Adenosine Receptor Ligands-Recent Developments Part I. Agonists
Current Medicinal Chemistry Perspectives on Medicinal Properties of Benzoquinone Compounds
Mini-Reviews in Medicinal Chemistry Mitochondrial Targeting for Development of Novel Drug Strategies in Brain Injury
Central Nervous System Agents in Medicinal Chemistry Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Current HIV Research Editorial: Bioengineering, Clinical and Therapeutical Trends in Transcatheter Aortic Valve Implantation
Current Pharmaceutical Design Marine Natural Products as a Promising Source of Therapeutic Compounds to Target Cancer Stem Cells
Current Medicinal Chemistry Multifaceted Individualities in Pharmacological Treatments of Obesity
Current Clinical Pharmacology Nitrogen Biobank for Cardiovascular Research
Current Cardiology Reviews Mitochondrial Triglyceride Transfer Protein Inhibition: New Achievements in the Treatment of Dyslipidemias
Current Pharmaceutical Design Acute Myocardial Infarction in Systemic Mastocytosis: Case Report With Literature Review on the Role of Inflammatory Process in Acute Coronary Syndrome
Current Cardiology Reviews